诺和诺德欧股初段跌逾5% 公司减肥药被特朗普点名大幅降价

AASTOCKS
Oct 17

丹麦诺和诺德药厂(Novo Nordisk)股价在欧洲早市跌5.6%,美国总统特朗普隔晚(16日)在一场关于生育治疗与药价的活动,点名该公司减肥药Ozempic将大幅降低售价。诺和诺德Ozempic药物获准用于治疗糖尿病,但与该集团畅销减肥药Wegovy含相同活性成分。Ozempic在美国经常被标签为用于肥胖治疗,并常被泛指为减肥药。(fc/da)AASTOCKS新闻

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10